Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by davikingon Jan 11, 2011 12:43pm

169 Views

Post# 17954319

RE: A Little Pumping

Oops, this contradicts the logic presented by your post and another on MWC. Hmm, why would they want to sell? Do they know something we don't.
"Because the Growthworks VP of investments sits on the SDI board of directors and would therefore have visibility to the latest progress report on the FDA trial setup. Knowing that, he wants shares, not cash."

Bullboard Posts

Eminent acquires promising Nevada gold project